Technology | 2011.09.23
Zymeworks Completes $8.1 Million Round of Financing to Advance Platform Technology and Therapeutics Pipeline Programs
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the completion of a financing totaling $8.1 million. The financing consists of a follow-on round of institutional investment by CTI Life Sciences Fund, L.P. (“CTI”), as well as a new investment by Advanced Biotechnologies Venture Fund (“ABVF”) and investments by several existing
For more information, please visit
http://www.businesswire.com/news/home/20[...]ion-Financing-Advance-Platform
